SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is trending as it celebrates its 50th anniversary amidst heightened institutional focus on its options activity and a patent infringement dispute with Xiao-I AI in China. The community is actively debating the potential impact of a settlement on Apple's valuation and the company's ability to maintain its market dominance during ongoing geopolitical tensions.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is seeing significant upward momentum after CMS finalized a higher-than-expected Medicare Advantage payment rate for 2027, sparking a massive rally that has triggered a potential short squeeze. While community discourse remains polarized between bullish investors celebrating the long-awaited revenue relief and skeptical bears questioning the sector's long-term regulatory headwinds and volatility, many traders are now closely monitoring whether the stock can hold these gains to fill previous gaps.

Avis Budget Group, Inc. engages in the provision of vehicle sharing and rental services. It operates through the Americas and International segments. The Americas segment includes vehicle rental and car sharing operations in North America, South America, Central America, and the Caribbean. The International segment is involved in vehicle rental and car sharing operations in Europe, the Middle East, Africa, Asia, and Australasia. The company was founded in 1946 and is headquartered in Parsippany, NJ.

Avis Budget Group Inc

Avis Budget Group (CAR) is seeing high volatility as market participants debate its stretched valuation against the backdrop of significant short interest and intense speculation regarding a potential short squeeze. Community members are actively analyzing the stock's technical price action and debt levels, with many traders closely monitoring whether the current momentum can be sustained or if the stock will revert toward fundamentally driven price levels.

Shido

Shido is seeing increased market attention driven by the successful inauguration of its BubblePad launchpad and the release of new DeFi tools like BubbleSwap, which are helping to strengthen its ecosystem liquidity. Investors are actively tracking the project's recent growth, specifically highlighting its consistent development pace and rising staking participation as indicators of long-term project confidence.

FuboTV, Inc. is a consumer-first live TV streaming company with the mission of delivering premium sports, news and entertainment programming that offers greater choice, flexibility and value. The company was founded by David Gandler, Alberto Horihuela Suarez, and Sung Ho Choi on February 20, 2009 and is headquartered in New York, NY.

fuboTV Inc - Ordinary Shares - Class A

fuboTV Inc

FuboTV is currently experiencing intense volatility as investors react to the company's long-term financial guidance and the aftermath of a recent reverse stock split. The community remains deeply divided, with bearish voices highlighting a sustained downward price trend and lack of management communication, while bullish participants are actively debating the potential for a short squeeze and speculating on long-term institutional interest.

iShares Trust - iShares Russell 2000 ETF

iShares Russell 2000 ETF

The iShares Russell 2000 ETF (IWM) is trending as market participants weigh heightened geopolitical instability surrounding the Strait of Hormuz against hopes for a diplomatic ceasefire. The community is actively debating the reliability of recent trade-related rhetoric from the White House, with many traders closely monitoring institutional hedging activity and potential signals for a broader regime shift in equity markets.

Klarna Group Plc is a global digital bank and flexible payments provider. It operates through an AI-powered payments and commerce network that empowers people to pay smarter, with a mission to be available everywhere, for everything. The company was founded by Gustav Erik Niklas Adalberth, Karl Anders Victor Jacobsson, and Sebastian Marcin Siemiatkowski in 2005 and is headquartered in London, the United Kingdom.

Klarna Group plc

Klarna is facing intense community debate as investors weigh significant insider stock purchases by leadership against concerns regarding high short interest and potential volatility following the expiration of lock-up periods. While some participants are betting on a short squeeze driven by dwindling share availability, others remain cautious, focusing on the company's path to profitability and upcoming legal catalysts.

Propy is a decentralized real-estate market place backed by superior blockchain infrastructure to facilitate real-time unified transaction in order to reduce fraud and redundancy. Propy is the world’s first international real-estate marketplace.

Propy

Propy is currently trending as investors debate its long-term potential in the RWA and AI real estate sector, with many focused on recent development news and accumulation activity despite ongoing volatility. While some community members remain skeptical of its historical price swings and algorithmic sell-offs, others view the current valuation as a strategic entry point for a long-term play in tokenized real estate.

Fundrise Innovation Fund LLC operates as a non-diversified, closed-end management investment company. It invests in growing tech companies to help them expand and generate profits. The company was founded on June 7, 2021 and is headquartered in Washington, DC.

Fundrise Innovation Fund LLC. - Common Shares of Limited Liability Company Interests

Fundrise Innovation Fund 

VCX is trending as retail investors engage in a heated debate over its massive premium to net asset value, with proponents betting on long-term exposure to high-growth private firms like SpaceX and Anthropic, while skeptics warn of an imminent correction following extreme volatility.

Blue Moon Metals Inc. engages in the acquisition and exploration of mineral resource properties. It focuses on Blue Moon zinc and Yava properties. The company was founded on January 15, 2007 and is headquartered in Vancouver, Canada.

Blue Moon Metals Inc

Blue Moon Metals is gaining significant attention following the successful acquisition of the Gage Project and the appointment of an experienced project leader, moves that bolster its strategy to consolidate domestic critical mineral assets. Investors are closely tracking the company's expanding portfolio of brownfield projects and its alignment with current policy tailwinds for strategic metals like germanium, gallium, and tungsten.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Roth Capital upgraded its rating on TRLY to ‘Overweight,’ while Alliance Global maintained ‘neutral.’</li><li>Last year, the U.S. tightened rules on hemp-derived THC products, and now various states are also restricting or banning those products.</li><li>On Wednesday, Tirlay reported fiscal third-quarter results.</li></ul>Tilray Brands, Inc.’s third-quarter report drew a mixed reaction from Wall Street, as analysts balanced improving business fundamentals against looming regulatory shifts that could disrupt the marijuana industry.TLRY shares declined 1.5% in early premarket trading on Thursday, following a 5% dip the previous session.Alliance Global lowered its price target on TLRY to $7 from $9 (14% upside projection), while keeping a ‘Neutral’ rating, citing uncertainty over hemp restrictions.In November, the U.S. government tightened hemp regulations by capping&nbsp;total levels of tetrahydrocannabinol (THC) — the primary psychoactive component in cannabis that produces a “high”&nbsp;— at 0.3%, while also restricting products such as Delta-8, effectively curbing many intoxicating hemp items, including edibles, vapes, and beverages. Last month, Texas added further pressure by banning smokable hemp products and raising licensing fees, with more states expected to follow suit.On the other hand, Roth Capital upgraded its rating on TLRY to ‘Buy’ from ‘Neutral’ with an unchanged $10 price target.&nbsp; The research firm praised Tilray’s upbeat results, particularly the Canadian and international segments. Tilray shares are back at July 2025 levels, but the fundamental outlook has improved, and the potential for regulatory change is greater, the firm added.<h2 class="st-heading-2">Q3 Results Recap</h2>Revenue rose 19% to $206.7 million, helped by sharp growth in international sales, and came in higher than the $201.3 million expectation. Net loss narrowed significantly to $25.2 million from $793.5 million a year earlier. On an adjusted basis, loss per share of $0.24 missed the analyst target of $0.14.Tilray said international sales increased 73%, while its Tilray Pharma segment grew 34%. The company reaffirmed its outlook for fiscal 2026 core earnings of $62 million to $72 million.<h2 class="st-heading-2">Retail, Analyst View On TLRY</h2>On Stocktwits, retail sentiment for TLRY shifted from ‘bullish’ to ‘bearish’ following the results.&nbsp;“$TLRY Slow and steady wins the race. It sure ain't Nvidia, but I'll take it. Slight dip in margins, amid a sea of price compression. Revenue beat, and earnings meet. Not bad,”&nbsp;<a href="https://stocktwits.com/davidjbenz/message/649151732">said</a> a user.To be sure, traders are trading stock in anticipation of the U.S. potentially classifying marijuana as a Schedule III (S3) drug, indicating that it has a lesser potential for abuse and is allowed for use in specific medical treatment.Marijuana remains a Schedule I drug under federal law — the same category as heroin and LSD – a classification reserved for substances deemed to have high abuse potential and no accepted medical use. Weed stocks, including TLRY, rallied sharply in December after President Donald Trump announced&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/trump-moves-a-step-closer-to-reclassifying-marijuana-as-a-less-dangerous-drug-a-breakout-moment-for-weed-industry/cLICa8WREFB">plans to reclassify</a>. It hasn’t happened yet.“Even without S3 record results, why are people so sad,”&nbsp;<a href="https://stocktwits.com/Tradefun1979/message/649157581">said</a> another Stocktwits user. “S3 is bonus but currently co. Is not doing bad, actually stellar results. I am buying and will hold Long term, very cheap now.”Meanwhile, Wall Street is in a wait-and-watch mode. Currently, seven out of 10 analysts have a ‘Hold’ rating on the stock, two rate it ‘Buy’, and one&nbsp;rates it ‘Strong Sell’, per Koyfin. Their average price target of $11.14 implies an over 80% upside from the stock’s last close.For updates and corrections, email newsroom[at]stocktwits[dot]com.&nbsp;

In this photo illustration, a Tilray Brands logo is seen displayed on a smartphone and in the background.

TLRY Stock Drops Premarket: Why Analysts Are Mixed Despite Upbeat Q3 Report 

Tirlay Brands shares have declined 33% year to date.

Equity

Tirlay Brands shares have declined 33% year to date.


Cannabis ETF (CNBS) Hits New 52-Week High

CNBS Cannabis ETF climbs to a 52-week high, fueled by rescheduling optimism and potential further gains.

<ul class="summary-bullets"><li>Tilray’s shares, as well as shares of other Cannabis producers, have been surging over the past few days.</li><li>This comes amid reports that President Trump is set to reclassify marijuana, which would result in cannabis companies falling under different tax regulations.</li><li>While awaiting the executive order, retail users on Stocktwits expressed optimism, noting that the TLRY stock could rally even further.</li></ul>Shares of Tilray Brands Inc. (TLRY) have soared nearly 72% over the past five trading sessions as investors await President Donald Trump’s executive order on marijuana reclassification.The New York City-headquartered pharmaceutical company produces and distributes cannabis for medicinal and adult use.Tilray’s shares, as well as shares of other Cannabis producers, have been surging over the past few days amid reports that President Trump is set to reclassify marijuana, which would result in cannabis companies falling under different tax regulations.<a href="https://stocktwits.com/symbol/TLRY">Tilray shares</a> were up nearly 5% in Wednesday’s pre-market trade. Retail sentiment on Stocktwits around the company trended in the ‘extremely bullish’ territory, with the stock being the top trending ticker on the platform at the time of writing.<h2 class="st-heading-2">Retail’s Excited</h2>While awaiting the executive order, retail users on Stocktwits expressed optimism, noting that the TLRY stock could rally even further. One user expects Tilray’s shares to surge past $20 on Wednesday with ease.<stembedurl>https://stocktwits.com/LifeChangingProfits/message/639396013</stembedurl>Another user compared the reclassification of marijuana to a biotech company receiving fast-track approval from the U.S. Food and Drug Administration (FDA) for ten Phase 3 trials simultaneously.<stembedurl>https://stocktwits.com/Hoschton30548/message/639132205</stembedurl>One user expects the TLRY stock to surge past $50 by the end of the year.<stembedurl>https://stocktwits.com/Family2328/message/639372092</stembedurl><h2 class="st-heading-2">Other Cannabis Stocks Surge</h2>Apart from Tilray, expectations of marijuana reclassification have sent other cannabis stocks soaring, too.Canopy Growth Corp. (CGC), an Ontario-based company, saw its shares climb nearly 62% over the past five trading sessions. Aurora Cannabis Inc. (ACB) shares have climbed over 20%, while the Amplify Seymour Cannabis ETF (CNBS) has soared nearly 71% during this period.<h2 class="st-heading-2">Marijuana Reclassification</h2>According to a&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://abcnews.go.com/Politics/trump-sign-executive-order-reclassifying-marijuana-officials/story?id=128472615">report</a> by ABC News citing people familiar with the matter, President Trump is set to sign an executive order on Wednesday that would reclassify marijuana as a Schedule III drug.Under the current Drug Enforcement Administration guidelines, marijuana is listed as a Schedule I drug. The DEA defines Schedule III drugs as having “a moderate to low potential for physical and psychological dependence.”<a href="https://stocktwits.com/symbol/TLRY">TLRY stock</a> is up 5% year-to-date and 16% over the past 12 months.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/ford-terminates-6-5-billion-battery-deal-lg-energy-after-retreating-from-evs/cLeOWmAREpD">Ford Terminates $6.5 Billion LG Energy Deal After Retreating From EVs — And Retail Is Split</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

TLRY Stock Gained Over 70% In 5 Days, Retail Optimism Spikes Ahead Of Trump's Marijuana Order

The New York City-headquartered pharmaceutical company produces and distributes cannabis for medicinal and adult use.

6 Top-Performing ETF Areas of Last Week 

Cannabis, metals, space and health care led ETF gains last week. WEED, CNBS, SIL, UFO, GDXJ, PLTM and OZEM outperformed despite tech weakness.

5 Best-Performing Leveraged ETFs of Last Week

Cannabis, space, nat gas & auto led last week's leveraged ETF winners. MSOX, RKLX, KOLD, VOYX and CVNX posted outsized gains despite tech weakness.

Cannabis ETFs Soar Double-Digits on Friday: Here's Why

Cannabis ETFs explode on reform buzz. CNBS, WEED, MSOS and MJ jumped double-digits on Dec. 12, 2025 as Trump reportedly weighs reclassifying marijuana, boosting optimism.

The Zacks Analyst Blog Highlights MSOS, CNBS, WEED, MJ and YOLO

Zacks Analyst Blog highlights MSOS, CNBS, WEED, MJ, and YOLO as marijuana ETFs soar over 100% in three months on U.S. legalization hopes and investor optimism.

From Loss to Lift-Off: Marijuana ETFs Rebound on Legalization Prospects 

Marijuana ETFs, such as WEED, MSOS, and CNBS, are rebounding as hopes for rescheduling boost investor optimism. 

Top-Performing ETF Areas of August That Are Up At Least 20% 

ETFs tied to Cannabis, Asia, China, materials and bitcoin miners led August's gains in Wall Street. ETFs like WEED, KSTR, CNXT, GBUG and WGMI won in August.

Cannabis ETFs Soar as Trump Mulls Over Marijuana Reclassification

Cannabis ETFs like WEED, CNBS and MJ surge after Trump confirmed that his administration is weighing marijuana's move from Schedule I to Schedule III.


Current Price	$24.50
Prev Close	$23.57
Open	$23.59
Dividend Yield	N/A
50-Day Moving Average	$23.86
Beta	N/A
Avg. Volume	8,880.45
PE Ratio	N/A

52-Week High	$43.94
52-Week Low	$13.96
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

CNBS
Amplify Seymour Cannabis ETF

Feed

News

Sentiment

Fundamentals

Info

Latest CNBS News

CNBSAmplify Seymour Cannabis ETF